PathWay Technology

Pathway Medical Technologies was a medical device company focused on developing innovative solutions for the treatment of peripheral artery disease (PAD). The company's flagship product, the Jetstream Atherectomy System, is a catheter-based platform designed to remove various types of arterial plaque and thrombus while simultaneously providing active aspiration. This technology allows for the restoration of blood flow in diseased vessels with a single device, reducing the need for multiple interventions. In 2011, the company was acquired by Bayer Medrad, significantly expanding the reach of its vascular intervention portfolio.